Oncology Clinical Trials in Scottsdale, AZ
As of June 2026, 119 paid clinical trials are recruiting for Oncology in Scottsdale, Arizona. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
119 clinical trials for Oncology
·Clear filters·↓ Download CSVAxatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Prevalence and Clinical Manifestations of Cannabis Withdrawal in Hospitalized Patients With Hematological Malignancies Undergoing Bone Marrow Transplant (BMT) or Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
Impact of Immunotherapy on Vestibular Function, The Mayo Clinic Arizona Experience
Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors
Q702 for the Treatment of Patients With Hematologic Malignancies
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Multi-Cancer Detection Observational Cohort Study
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
About research studies in Scottsdale
Scottsdale has approximately 428 recruiting research studies across a wide range of therapeutic areas. Arizona is home to Mayo Clinic Arizona, Banner - University Medical Center, and TGen (Translational Genomics Research Institute), with active research in oncology and precision medicine.
Top Research Study Locations in Scottsdale
Researchers run research studies in Scottsdale, AZ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Mayo Clinic in Arizona | Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Breast Carcinoma | 99 |
| Mayo Clinic | Breast Cancer, Colorectal Neoplasms, Prostate Cancer | 27 |
| Mayo Clinic Arizona | Esophageal Adenocarcinoma, Healthy, Advanced Solid Tumor | 25 |
| HonorHealth Research Institute | Solid Tumor, Advanced Solid Tumor, Colorectal Adenocarcinoma | 20 |
| HonorHealth | Advanced Pancreatic Ductal Adenocarcinoma, Advanced Prostate Cancer, Advanced Solid Tumors | 15 |
| Honor Health Research Institute | Generalized Myasthenia Gravis, Non Small Cell Lung Cancer, Non-Hodgkin Lymphoma | 14 |
| Honor Health | Acute Ischemic Stroke, Acute Myocardial Infarction (AMI), Adamantinomatous Craniopharyngioma | 13 |
| Scottsdale Clinical Trials | Diabetic Peripheral Neuropathic Pain, Alzheimer Disease, Celiac Disease | 7 |
| Headlands Research - Scottsdale | Obesity, Overweight, Alcohol Use Disorder | 6 |
| Ironwood Cancer & Research Centers | Advanced Non-Small Cell Lung Cancer, Breast Cancer, Cancer of the Prostate | 6 |
| Mayo Clinic - Scottsdale | Angiosarcoma, Breast Cancer, Breast Neoplasms | 5 |
| Arizona Center for Cancer Care - Scottsdale | Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 | 4 |
| HonorHealth Research and Innovation Institute | Active Refractory Rheumatoid Arthritis, Advanced Solid Tumor, CRC | 4 |
| Mayo Clinic Scottsdale | Lung Cancer, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS) | 4 |
| Mayo Clinic in Arizona - Scottsdale | Crohn Disease, Colitis, Ulcerative, Myositis | 4 |
| Research Network Arizona | Macular Edema Secondary to Inflammation, Diabetic Macular Edema, Neovascular Age-Related Macular Degeneration (nAMD) | 4 |
| HonorHealth Neurology | Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Degenerative Lumbar Disc Disease, Myasthenia Gravis | 3 |
| HonorHealth Research & Innovation Institute | ASCVD, Aortic Valve Disease Mixed, Aortic Valve Regurgitation | 3 |
| HonorHealth Scottsdale Osborn Medical Center | Glioblastoma, LE ALI, Lower Extremity Acute Limb Ischemia | 3 |
| Perseverance Research Center | Alzheimer Dementia, Late Onset Alzheimer Disease, Multiple Sclerosis (MS) Primary Progressive | 3 |
| Retina Macula Institute of Arizona | Age-related Macular Degeneration (AMD), DME, Diabetic Macular Edema | 3 |
| Scottsdale, Arizona | Branch Retinal Vein Occlusion (BRVO), Hypertension, Pulmonary, Idiopathic Hypersomnia | 3 |
| Vincere Cancer Center | Cancer | 3 |
| Center for Dermatology and Plastic Surgery | Dermatitis Atopic, Acne | 3 |
| GSK Investigational Site | Scleroderma, Systemic, Systemic Lupus Erythematosus, Systemic Sclerosis Associated Interstitial Lung Disease | 2 |
Active & Upcoming Studies in Scottsdale (2026)
Recruiting trials in Scottsdale grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (138 active studies)
- A Physical Activity Program Compared to Health Education for Improving Memory and Attention in Hispanic Women With Newly-Diagnosed Stage I-IIIa Breast Cancer, MAMA Trial · Mayo Clinic
- IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) · Phase 3 · Ono Pharmaceutical Co., Ltd.
Neurology & pain (30 active studies)
Cardiovascular (18 active studies)
- Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease · Phase 2 · Tectonic Operating Company, Inc.
- Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM) · Biobeat Technologies Ltd.
Diabetes & metabolic (13 active studies)
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
- A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study) · Aqua Medical, Inc.
Eye & vision (12 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Mental health & behavior (4 active studies)
- Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD · Phase 1 · Suzanne "Sue" Sisley MD
- Senyo Health With Substance Use Disorder (SUD) in Primary Care · Mayo Clinic
Vaccines (2 active studies)
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Scottsdale
- Malignant Solid Neoplasm (14 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Hematopoietic and Lymphatic System Neoplasm (11 active studies). Recruiting Hematopoietic and Lymphatic System Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Cancer (9 active studies). Recruiting Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Solid Tumor (9 active studies). Recruiting Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Advanced Solid Tumor (8 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer (8 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Scottsdale
- Mayo Clinic
- Eli Lilly and Company
- Pfizer
- Sanofi
- Novartis Pharmaceuticals
Local regulations and guidelines
Clinical trials in Arizona are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Arizona research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Scottsdale. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Scottsdale
Hipa.ai aggregates every recruiting study in Scottsdale from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Scottsdale?
There are approximately 428 recruiting clinical trials in Scottsdale, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Scottsdale pay participants?
Most recruiting trials in Scottsdale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Scottsdale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Scottsdale?
The most common conditions under active study in Scottsdale include Malignant Solid Neoplasm (14), Hematopoietic and Lymphatic System Neoplasm (11), Cancer (9), Solid Tumor (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Scottsdale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Scottsdale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Scottsdale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Scottsdale?
Recruiting research sites in Scottsdale include Mayo Clinic in Arizona, Mayo Clinic, Mayo Clinic Arizona, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Scottsdale right now?
The largest active categories in Scottsdale are Cancer & tumors (138), Neurology & pain (30), Cardiovascular (18). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.